KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Illumina (ILMN) Asset Writedowns and Impairment (2017 - 2024)

Illumina filings provide 4 years of Asset Writedowns and Impairment readings, the most recent being $1.9 billion for Q2 2024.

On a quarterly basis, Asset Writedowns and Impairment changed N/A to $1.9 billion in Q2 2024 year-over-year; TTM through Jun 2025 was $1.9 billion, a 30.48% decrease, with the full-year FY2024 number at $1.9 billion, up 128.42% from a year prior.
Asset Writedowns and Impairment hit $1.9 billion in Q2 2024 for Illumina, up from $6.0 million in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $1.9 billion in Q2 2024 to a low of $6.0 million in Q4 2023.